CD79A and rheumatoid arthritis: In fact, immunoglobulin (Ig)A-antibodies (ACPAs, RF) and IgA-plasmablasts are enriched in preclinical RA and predict evolution to overt disease, supporting the possible participation of mucosal immunity since the early pathophysiological stages (6, 13, 49).